ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer.
about
ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
ATR-Chk1 signaling inhibition ...... in urothelial bladder cancer.
@ast
ATR-Chk1 signaling inhibition ...... in urothelial bladder cancer.
@en
type
label
ATR-Chk1 signaling inhibition ...... in urothelial bladder cancer.
@ast
ATR-Chk1 signaling inhibition ...... in urothelial bladder cancer.
@en
prefLabel
ATR-Chk1 signaling inhibition ...... in urothelial bladder cancer.
@ast
ATR-Chk1 signaling inhibition ...... in urothelial bladder cancer.
@en
P2093
P2860
P356
P1433
P1476
ATR-Chk1 signaling inhibition ...... y in urothelial bladder cancer
@en
P2093
Chia-Lin Lee
Chieh-Yu Peng
Ching-Chia Li
Da-Yong Zhang
Juan-Cheng Yang
Mei-Chin Lu
Wei-Yu Hsu
Wen-Jeng Wu
Yang-Chang Wu
Yun-Hao Dai
P2860
P304
P356
10.18632/ONCOTARGET.6482
P407
P577
2016-01-01T00:00:00Z